We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current OTSKF market cap is 22.8B. The company's latest EPS is JPY 218.0140 and P/E is 0.19.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 1.4T | 1.43T | 1.5T | 1.74T | 2.02T |
| Operating Income | 178.47B | 199.5B | 154.41B | 133.97B | 140.59B |
| Net Income | 127.15B | 148.14B | 125.46B | 134.02B | 121.62B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 2.58T | 2.63T | 2.82T | 3.1T | 3.36T |
| Total Liabilities | 785.87B | 744.37B | 775.73B | 840.17B | 924.93B |
| Total Equity | 1.8T | 1.88T | 2.05T | 2.26T | 2.44T |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 192.63B | 232.84B | 228.86B | 211.85B | 283.23B |
| Investing | -52.28B | -99.86B | -95.29B | -81.58B | -190.54B |
| Financing | -89.27B | -104.93B | -95.84B | -95.47B | -60.26B |
| Market Cap | 22.8B |
| Price to Earnings Ratio | 0.19 |
| Price to Sales Ratio | 0.01 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 557.84M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 610 |
| 52 Week Change | 8.29% |
| 52 Week High | 41.59 |
| 52 Week Low | 35.91 |
| Spread (Intraday) | 3.37 (7.82%) |
| Company Name | Otsuka Holdings Company Ltd (PK) |
| Address |
2-9 kanda-tsukasamachi chiyoda, tokyo 101-0048 |
| Website | https://www.otsuka.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
